4 Pathophysiology of thalassaemia

Most of the major clinical manifestations of the β-thalassaemias can be related to the deleterious effects of imbalanced globin chain synthesis on erythroid maturation and red cell survival. The destruction of red cell progenitors and their progeny results from an extremely complex series of mechanisms all related to the presence of excess α-globin chain production. These include mechanical damage, interference with cell division and oxidative destruction of both organelles and components of the red cell membrane. The unequal distribution of γ-globin chains between different precursors, and the intense selection of those with relatively higher levels of γ chain production, lead to an extremely heterogeneous cell population in the peripheral blood. Iron overload, due to increased gastrointestinal absorption and blood transfusion is the major cause of tissue damage, morbidity and death.

[1]  Y. C. Chang,et al.  Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2 , 1992 .

[2]  S. Fucharoen,et al.  Hypoxaemia and the effect of aspirin in thalassaemia. , 1981, The Southeast Asian journal of tropical medicine and public health.

[3]  D. Weatherall,et al.  Studies of Red‐Cell Membrane Function in Heterozygous β Thalassaemia and Other Hypochromic Anaemias , 1974, British journal of haematology.

[4]  R. Gunn,et al.  Influence of hemoglobin precipitation on erythrocyte metabolism in alpha and beta thalassemia. , 1969, The Journal of clinical investigation.

[5]  E. Shinar,et al.  Oxidative denaturation of red blood cells in thalassemia. , 1990, Seminars in hematology.

[6]  A. Oppenheim,et al.  Genetic analysis of β‐thalassemia intermedia in Israel: Diversity of mechanisms and unpredictability of phenotype , 1997, American journal of hematology.

[7]  P. Fessas.  Inclusions of Hemoglobin in Erythroblasts and Erythrocytes of Thalassemia , 1963 .

[8]  G. Stamatoyannopoulos,et al.  The molecular basis of blood diseases , 1987 .

[9]  S. Fucharoen,et al.  Cardiac pathology in 47 patients with beta thalassaemia/haemoglobin E. , 1984, The Southeast Asian journal of tropical medicine and public health.

[10]  J. Clegg,et al.  Haemoglobin Constant Spring—A Chain Termination Mutant ? , 1971, Nature.

[11]  J. B. Clegg,et al.  The thalassaemia syndromes , 1965 .

[12]  P. Fondu,et al.  Neutrophil dysfunctions in thalassaemia major: The role of cell iron overload , 1987, European journal of haematology.

[13]  O. Olivieri,et al.  Hemoglobin Variants and Activity of the (K'Cl-) Cotransport System in Human Erythrocytes , 1992 .

[14]  Graziano Jh.  Potential usefulness of free radical scavengers in iron overload. , 1976 .

[15]  E. Fibach,et al.  Erythropoietin activity in the serum of beta thalassemic patients. , 2009, Scandinavian journal of haematology.

[16]  S. Wickramasinghe,et al.  Composition of the intra‐erythroblastic precipitates in thalassaemia and congenital dyserythropoietic anaemia (CDA): identification of a new type of CDA with intra‐erythroblastic precipitates not reacting with monoclonal antibodies to α‐ and β‐globin chains , 1996, British journal of haematology.

[17]  Y. Barenholz,et al.  Phosphatidylserine in the outer leaflet of red blood cells from β‐thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes , 1993 .

[18]  W. Wood.  7 Increased HbF in adult life , 1993 .

[19]  P. Suwanagool,et al.  Distribution of pulmonary thromboembolic lesions in thalassemic patients. , 1987, Birth defects original article series.

[20]  R. Diez,et al.  Progressive dysfunction of monocytes associated with iron overload and age in patients with thalassemia major. , 1986, Blood.

[21]  E. Shinar,et al.  Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia. , 1989, The Journal of clinical investigation.

[22]  S. Fucharoen,et al.  Pulmonary artery obstruction in thalassaemia. , 1980, The Southeast Asian journal of tropical medicine and public health.

[23]  B. Thorell,et al.  Hemichromes in single inclusion bodies in red cells of beta thalassemia. , 1972, Blood.

[24]  R. Advani,et al.  Characterization and comparison of the red blood cell membrane damage in severe human alpha- and beta-thalassemia. , 1992, Blood.

[25]  S. Schrier.  Thalassemia: pathophysiology of red cell changes. , 1994, Annual review of medicine.

[26]  A. Eldor,et al.  Increased Procoagulant Activity of Red Blood Cells from Patients with Homozygous Sickle Cell Disease and β-Thalassemia , 1996, Thrombosis and Haemostasis.

[27]  J. Adamson,et al.  FERROKINETICS IN MAN , 1970, Medicine.

[28]  R. Schwartz,et al.  The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes. , 1985, Clinics in haematology.

[29]  D. Weatherall,et al.  Iron-chelating therapy. , 1988, Critical reviews in clinical laboratory sciences.

[30]  S. Schrier,et al.  Accelerated programmed cell death (apoptosis) in erythroid precursors of patients with severe beta-thalassemia (Cooley's anemia) [see comments] , 1993 .

[31]  R. Gunn,et al.  Thalassemia: the consequences of unbalanced hemoglobin synthesis. , 1966, The American journal of medicine.

[32]  V. Lew,et al.  Calcium transport and ultrastructure of red cells in beta-thalassemia intermedia. , 1988, Blood.

[33]  J. Clegg,et al.  Molecular basis for dominantly inherited inclusion body beta-thalassemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Hall,et al.  Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? , 1998, British journal of haematology.

[35]  D. Miller,et al.  RED BLOOD CELL METABOLISM AND FUNCTION IN TRANSFUSED β‐THALASSEMIA * , 1974 .

[36]  S. Vincent.  Oxidative effects of heme and porphyrins on proteins and lipids. , 1989, Seminars in hematology.

[37]  M. Cazzola,et al.  Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia major , 1995, British journal of haematology.

[38]  Alan R. Cohen,et al.  Incidence and treatment of fractures in thalassemia. , 1988, Journal of orthopaedic trauma.

[39]  E. Rachmilewitz,et al.  Non‐Specific Serum Iron in Thalassaemia: an Abnormal Serum Iron Fraction of Potential Toxicity , 1978, British journal of haematology.

[40]  R. Girot,et al.  Bone disease in children with homozygous β-thalassemia , 1990 .

[41]  E. Shinar,et al.  2 Haemoglobinopathies and red cell membrane function , 1993 .

[42]  S. Schrier,et al.  Erythrocyte membrane alterations in beta-thalassaemia. , 1985, Clinics in haematology.

[43]  B. Modell,et al.  The Clinical Approach to Thalassaemia , 1984 .

[44]  G. Brittenham,et al.  The effect of erythroid hyperplasia on iron balance. , 1988, Blood.

[45]  G. Lathrop,et al.  Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach , 1996, Nature Genetics.

[46]  D. Weatherall,et al.  The role of genomics in studying genetic susceptibility to infectious disease. , 1997, Genome research.

[47]  D. Weatherall,et al.  Regular Review: Iron and infection , 1988, Bailliere's clinical haematology.

[48]  F. Petraglia,et al.  Reduced spinal bone density in young women with amenorrhoea. , 1991, European journal of obstetrics, gynecology, and reproductive biology.

[49]  I. Mackie,et al.  Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion , 1995, British journal of haematology.

[50]  C. Hershko,et al.  Heart cells in culture: a model of myocardial iron overload and chelation. , 1985, The Journal of laboratory and clinical medicine.

[51]  N. Mohandas,et al.  Hydration of red cells in α and β thalassemias differs : a useful approach to distinguish between these red cell phenotypes , 1994 .

[52]  Margarita L. G. Anapllotou,et al.  The contribution of hypogonadism to the development of osteoporosis in thalassaemia major: new therapeutic approaches , 1995, Clinical endocrinology.

[53]  L. Blendis,et al.  Some Effects of Splenectomy in Thalassaemia Major , 1974, British journal of haematology.

[54]  B. Halliwell,et al.  1 Iron toxicity and oxygen radicals , 1989 .

[55]  D. Templeton,et al.  Effects of iron loading on uptake, speciation, and chelation of iron in cultured myocardial cells. , 1993, The Journal of laboratory and clinical medicine.

[56]  D. Weatherall,et al.  IRON ABSORPTION AND LOADING IN β-THALASSÆMIA INTERMEDIA , 1979, The Lancet.

[57]  S. Schrier,et al.  Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: implication for differences in clinical manifestations. , 1989, Blood.

[58]  N. Olivieri,et al.  Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. , 1995, Blood.

[59]  P. Low,et al.  Partial characterization of the copolymerization reaction of erythrocyte membrane band 3 with hemichromes. , 1987, Biochemistry.

[60]  S. Schrier.  Pathobiology of thalassemic erythrocytes , 1997, Current opinion in hematology.

[61]  T. Iancu.  12 Ultrastructural pathology of iron overload , 1989 .

[62]  S. Mann,et al.  Ciba Foundation Symposium , 1997 .

[63]  B. Halliwell,et al.  Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. , 1985, Clinical science.

[64]  M. G. Pittis,et al.  Decreased phagolysosomal fusion of peripheral blood monocytes from patients with thalassemia major. , 1994, Acta haematologica.

[65]  Erythrocyte membrane skeleton abnormalities in severe beta-thalassemia , 1987 .

[66]  E. Rachmilewitz,et al.  Advances in the pathophysiology and treatment of thalassemia. , 1995, Critical reviews in oncology/hematology.

[67]  D. Jackson,et al.  Hormonal changes in thalassaemia major. , 1976, Archives of disease in childhood.

[68]  D. Weatherall.  The molecular basis for phenotypic variability of the common thalassaemias. , 1995, Molecular medicine today.

[69]  J. Clegg,et al.  Hematologic and biosynthetic studies in homozygous hemoglobin Constant Spring. , 1984, The Journal of clinical investigation.

[70]  S. Schrier,et al.  Abnormal assembly of membrane proteins in erythroid progenitors of patients with beta-thalassemia major. , 1996, Blood.

[71]  S. Schrier,et al.  Impaired erythrocyte calcium homeostasis in beta-thalassemia. , 1984, Blood.

[72]  S. Pontremoli,et al.  The Correlation between Red‐Cell Survival and Excess of α‐Globin Synthesis in β‐Thalassaemia , 1969 .

[73]  P. Rowley,et al.  Thalassemia: Pathophysiology and management. Part A , 1988 .

[74]  D. Bachir,et al.  A study of membrane protein defects and alpha hemoglobin chains of red blood cells in human beta thalassemia. , 1989, The Journal of biological chemistry.